Antiadhesion Therapy for Urinary Tract Infections—A Balanced PK/PD Profile Proved To Be Key for Success
Authors:
- 23 April 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (10) , 4700-4713
Abstract
The initial step for the successful establishment of urinary tract infections (UTIs), predominantly caused by uropathogenic Escherichia coli, is the adhesion of bacteria to urothelial cells. This attachment is mediated by FimH, a mannose-binding adhesin, which is expressed on the bacterial surface. To date, UTIs are mainly treated with antibiotics, leading to the ubiquitous problem of increasing resistance against most of the currently available antimicrobials. Therefore, new treatment strategies are urgently needed, avoiding selection pressure and thereby implying a reduced risk of resistance. Here, we present a new class of highly active antimicrobials, targeting the virulence factor FimH. When the most potent representative, an indolinylphenyl mannoside, was administered in a mouse model at the low dosage of 1 mg/kg (corresponding to approximately 25 μg/mouse), the minimal therapeutic concentration to prevent UTI was maintained for more than 8 h. In a treatment study, the colony-forming units in the bladder could be reduced by almost 4 orders of magnitude, comparable to the standard antibiotic treatment with ciprofloxacin (8 mg/kg, sc).Keywords
This publication has 51 references indexed in Scilit:
- Treatment and Prevention of Urinary Tract Infection with Orally Active FimH InhibitorsScience Translational Medicine, 2011
- Development of an aggregation assay to screen FimH antagonistsJournal of Microbiological Methods, 2010
- Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH AntagonistsJournal of Medicinal Chemistry, 2010
- Structural Basis for Mechanical Force Regulation of the Adhesin FimH via Finger Trap-like β Sheet TwistingCell, 2010
- Significance of Protein Binding in Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2010
- Origins and virulence mechanisms of uropathogenic Escherichia coliExperimental and Molecular Pathology, 2008
- The affinity of the FimH fimbrial adhesin is receptor‐driven and quasi‐independent of Escherichia coli pathotypesMolecular Microbiology, 2006
- Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse ModelAntimicrobial Agents and Chemotherapy, 2003
- Bacterial lectins, cell‐cell recognition and infectious diseaseFEBS Letters, 1987
- Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coliBiochemical and Biophysical Research Communications, 1982